Litigation

Recent Posts

Abbott Withdraws Diet Pill Meridia In United States, Canada
Posted on 8 Oct 2010 by LexisNexis Litigation Resource Community Staff

WASHINGTON, D.C. — (AP) Abbott Laboratories said Friday it will withdraw its diet pill Meridia in the U.S. and Canada, after coming under pressure from health regulators who say the drug increases the risk of heart attack and stroke in patients... Read More

Tags: weight loss , Wyeth , Vivus Inc. , Dr. John Jenkins , Food and Drug Administration , Abbott Laboratories , diet drugs , diet pill , Meridia , FDA , fen-phen , Arena Pharmaceuticals , Litigation , lawsuit , Roche , Health Canada , Xenical , Qnexa

Watchdog Group Makes 2nd Push To Ban Diet Pill
Posted on 15 Apr 2011 by LexisNexis Litigation Resource Community Staff

WASHINGTON, D.C. - (AP) For the second time in five years, public health advocates are calling on the Food and Drug Administration to ban a fat-blocking drug sold over-the counter and via prescription, pointing to new reports of kidney stones and pancreatic... Read More

Tags: Pondimin , Wyeth , obesity , Food and Drug Administration , Darvon , Public Citizen , Alli , diet drugs , diet pill , Meridia , FDA , Orlistat , fen-phen , fenfluramine , Redux , Litigation , GlaxoSmithKline , Roche , Xenical

6th Circuit Reverses Preemption-Based Dismissal Of Diet Drug Negligence Claims
Posted on 18 Aug 2010 by Michael Lefkowitz

CINCINNATI - (Mealey's) Citing the Supreme Court's rejection of implied preemption of pharmaceutical product liability in Wyeth v. Diana Levine (No. 06-1249, U.S. Sup.; 2009 U.S. LEXIS 1774), the Sixth Circuit U.S. Court of Appeals on Aug. 18... Read More

Tags: Supreme Court , drugs , punitive damages , Wyeth , preemption , PPH , Oliver Wimbush v. Wyeth , design defect , tort , personal injury , Wyeth v. Diana Levine , diet drugs , 6th Circuit , Tobin v. Astra Pharm. Produs. , Food Drug and Cosmetic Act , Reduc , FDCA , Longs v. Wyeth , Litigation , primary pulmonary hypertension

Abbott Withdraws Diet Drug Meridia From U.S. Market
Posted on 8 Oct 2010 by Tom Moylan

ABBOTT PARK, Ill. - (Mealey's) After an unfavorable assessment by a Food and Drug Administration expert committee regarding cardiovascular risk, Abbott Laboratories on Oct. 8 agreed with an FDA request to withdraw the weight-loss drug Meridia (sibutramine... Read More

Tags: sibutramine , weight loss , Sibutramine Cardiovascular Outcomes Trial , Steering Committee v. Abbott Laboratories , Center for Drug Evaluation and Research , Food and Drug Administration , Abbott Laboratories , diet drugs , SCOUT , Meridia , FDA , Office of New Drugs , Litigation , multidistrict litigation , Endocrinologic and Metabolic Drugs Committee , Meridia Products Liability Litigation , MDL , John Jenkins , black-box warning

Negligent Design Claim Reinstated on Appeal In Diet Drug Death Case
Posted on 3 Aug 2010 by Michael Lefkowitz

PHILADELPHIA - (Mealey's) A claim for negligent design is not subsumed in Pennsylvania's prohibition on strict liability claims against pharmaceutical manufacturers, the state Superior Court ruled Aug. 2 in a case asserting that Wyeth's diet... Read More

Tags: negligent design , Wyeth , PPH , dexfenfluramine , tort , personal injury , Patsy Lance , diet drugs , Patsy Lance v. Wyeth , Redux , Litigation , lawsuit , Catherine Ruth Lance , primary pulmonary hypertension

$42 Million Judgment Against Fen-Phen Lawyers Vacated
Posted on 7 Feb 2011 by Michael Lefkowitz

FRANKFORT, Ky. -- A $42 million summary judgment in favor of 431 fen-phen plaintiffs against a group attorneys, two of whom are serving lengthy prison sentences stemming from allegations that they pocketed twice what their fee agreements called for, has... Read More

Tags: American Home Products , Wyeth , Kentucky Court of Appeals , Chesley , Mills , Shirley A. Cunningham , Cunningham , Judgment , diet drugs , fen-phen , v. Mildred Abbott , legal fees , KFHL , Kentucky Fund for Healthy Living , Litigation , lawsuit , AHP